On behalf of the Dutch Ministry of VWS (Health, Welfare and Sport), RIVM has published new data on tobacco products. For the first time, these data include the ingredients of e-cigarettes, heated tobacco products and herbal smoking products.

From 1 October 2023, the blood of newborn babies will also be tested for the metabolic disorder adrenoleukodystrophy (ALD). This is done with the heel prick screening test.

There are a number of measures that can be implemented to make cigarettes less appealing and less addictive. For example, manufacturers could make cigarettes a darker colour. They could also stop using ingredients like sugars and flavourings.

The goal of the European Tobacco Products Directive is to make tobacco products and e-cigarettes less harmful, addictive and attractive. The directive does not specifically state which substances are not allowed in tobacco products and e-cigarettes.

From 1 April 2023, the Non-Invasive Prenatal Test (NIPT) will be available to all pregnant women. They do not have to take part in a scientific study for this.

Since October 2022, is it has become easier for transgender and intersex persons to take part in cervical cancer screening and breast cancer screening. Transgender and intersex persons with a uterus and/or breast tissue can register with Bevolkingsonderzoek Nederland.

From 1 June 2022, the heel prick test for Dutch newborns will also screen for spinal muscular atrophy (SMA). SMA is a serious hereditary muscle condition. Detecting this disease at an early stage enables early treatment.

Immigrants are relatively less likely to take part in preventive screening programmes, such as cancer screening. This is partly due to the language barrier and a lack of knowledge, according to a doctoral thesis by Nora Hamdiui.

The awareness and use of cigarillos, heated tobacco and nicotine pouches is relatively low. This is apparent from research by RIVM among Dutch people aged 13 and older, commissioned by the Ministry of Health, Welfare and Sport.